In this study, we conducted a comprehensive analysis of SKA1/2/3 at the pan-cancer level, including gene alterations (mutation, copy number, methylation), expression, prognostic value, pathway enrichment, effects on the tumor microenvironment (TME) and immunotherapy. Here, SKA1 is linked to neoplasm.